Abstract
Evidence suggests that endothelial cell layer heparan sulfate proteoglycans include a variety of different sized molecules which most likely contain different protein cores. In the present report, approximately half of endothelial cell surface associated heparan sulfate proteoglycan is shown to be releasable with soluble heparin. The remaining cell surface heparan sulfate proteoglycan, as well as extracellular matrix heparan sulfate proteoglycan, cannot be removed from the cells with heparin. The heparin nonreleasable cell surface proteoglycan can be released by membrane disrupting agents and is able to intercalate into liposomes. When the heparin releasable and nonreleasable cell surface heparan sulfate proteoglycans are compared, differences in proteoglycan size are also evident. Furthermore, the intact heparin releasable heparan sulfate proteoglycan is closer in size to proteoglycans isolated from the extracellular matrix and from growth medium than to that which is heparin nonreleasable. These data indicate that cultured porcine aortic endothelial cells contain at least two distinct types of cell surface heparan sulfate proteoglycans, one of which appears to be associated with the cells through its glycosaminoglycan chains. The other (which is more tightly associated) is probably linked via a membrane intercalated protein core.
Similar content being viewed by others
Abbreviations
- ECM:
-
extracellular matrix
- HSPG:
-
heparan sulfate proteoglycan
- PAE:
-
porcine aortic endothelial
- PBS:
-
phosphate buffered saline
References
Gill PJ, Silbert CK, Silbert JE: Effects of heparan sulfate removal on attachment and reattachment of fibroblasts and endothelial cells. Biochemistry 25: 405–410, 1986
Cheng C-F, Oosta GM, Bensadoun A, Rosenberg RD: Binding of lipoprotein lipase to endothelial cells in culture. J Biol Chem 256: 12893–12898, 1981
Shimada K, Gill PJ, Silbert JE, Douglas WHJ, Fanburg BL: Involvement of cell surface heparan sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. J Clin Invest 68: 995–1002, 1981
Williams MP, Streeter HB, Wusteman FS, Cryer A: Heparan sulfate and the binding of lipoprotein lipase to porcine thoracic aorta endothelium. Biochim Biophys Acta 756: 83–91, 1983
Thornton SC, Mueller SN, Levine EM: Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 222: 623–625, 1983
Imamura T, Mitsui Y: Heparan sulfate and heparin as a potentiator or a supressor of growth of normal and transformed vascular endothelial cells. Exp Cell Res 172: 92–100, 1987
Colbourn P, Buonassisi V: Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans. Biochem Biophys Res Commun 104: 220–227, 1982
Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD: Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem 261: 7507–7517, 1986
Kanwar YS, Jakubowski ML, Rosenzweig LJ, Gibbons JT: De novo cellular synthesis of sulfated proteoglycans of the developing renal glomerulus in vivo. Proc Natl Acad Sci USA 81: 7108–7111, 1984
Kanwar YS, Linker A, Farquhar MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86: 688–693, 1980
Castellot JJ Jr, Addonizio ML, Rosenberg R, Karnovsky MJ: Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 90: 372–379, 1981
Hassell JR, Kimura JH, Hascall VC: Proteoglycan core families. Ann Rev Biochem 55: 539–567, 1986
Kjellen L, Oldberg A, Rubin K, Höök M: Binding of heparin and heparan sulfate to rat liver cells. Biochem Biophys Res Commun 74: 126–133, 1977
Kramer RH, Vogel KG, Nicolson GL: Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem 257: 2678–2686, 1982
Oohira A, Wight TN, Bornstein P: Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem 258: 2014–2021, 1983
Robinson J, Gospodarowicz D: Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells. J Cell Physiol 117: 368–376, 1983
Winterbourne DJ, Schor AM, Gallagher JT: Synthesis of glycosaminoglycans by cloned bovine endothelial cells cultured on collagen gels. Eur J Biochem 135: 271–277, 1983
Lindblom A, Carlstedt I, Fransson L-A: Identification of core proteins in proteoglycans synthesized by vascular endothelial cells. Biochem J 261: 145–153, 1989
Kinsella MG, Wight TN: Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures. Biochemistry 27: 2136–2144, 1988
Humphries DE, Lee S-L, Fanburg BL, Silbert JE: Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells. J Cell Physiol 126: 249–253, 1986
Kinsella MG, Wight TN: Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol 102: 679–687, 1986
Morrison P, Lowe-Krentz LJ: Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate. Exp Cell Res 285: 304–315, 1989
Bârzu T, Molho P, Tobelen G, Petitou M, Caen J: Binding and endocytosis of heparin by human endothelial cells in culture. Biochim Biophys Acta 845: 196–203, 1985
Glimelius B, Busch C, Höök M: Binding of heparin on the surface of cultured human endothelial cells. Thrombosis Res 12: 773–782, 1978
Underhill CB, Keller JM: A transformation-dependent difference in the heparan sulfate associated with the cell surface. Biochem Biophys Res Commun 63: 448–454, 1975
Underhill CB, Keller JM: Heparan sulfates of mouse cells. Analysis of parent and transformed 3T3 cell lines. J Cell Physiol 90: 53–60, 1977
Lowe-Krentz LJ, Keller JM: Disulfide-bonded aggregates of heparan sulfate proteoglycans. Biochemistry 23: 2621–2627, 1984
Lowe-Krentz LJ, Keller JM: Multiple heparan sulfate proteoglycans synthesized by a basement membrane producing murine embryonal carcinoma cell line. Biochemistry 22: 4412–4419, 1983
Keller KL, Underhill, CB, Keller JM: Multiple types of cell surface heparan sulfate are produced by primary cultures of embryonic mouse cells. Biochim Biophys Acta 540: 431–442, 1978
Rapraeger AC, Bernfield M: Heparan sulfate proteoglycans from mouse mammary epithelial cells: a putative membrane proteoglycan associates quantitatively with lipid vesicles. J Biol Chem 258: 3632–3636, 1983
Keller KM, Keller JM, Moy JN: Heparan sulfates from swiss mouse 3T3 and SV3T3 cells: O-sulfate difference. Biochemistry 19: 2529–2536, 1980
Lowe-Krentz LJ, Joyce JG: Venous and aortic endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge. Anal Biochem 193: 155–163, 1991
Lowe-Krentz LJ, Keller J: Extracellular matrix producing M1536-B3 cells have receptors which bind heparin and heparan sulfate (Abstr.) J Cell Biol 99: 166a, 1984
Hiss D, Scott-Burden T, Gevers W: Disulfide-bonded heparan sulfate proteoglycans associated with the surfaces of cultured bovine vascular endothelial cells. Eur J Biochem 162: 89–94, 1987
Saunders S, Jalkanen M, O'Farrell S, Bernfield M: Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108: 1547–1556, 1989
Marynen P, Zhang J, Cassiman J-J, Van den Berghe H, David G: Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. J Biol Chem 264: 7017–7024, 1989
David G, Lories V, Decock B, Marynen P, Cassiman J-J, Van den Berghe H: Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 111: 3165–3176, 1990
Iozzo RV, Kovalszky I, Hacobian N, Schick PK, Ellingson JS, Dodge GR: Fatty acylation of heparan sulfate proteoglycan from human colon carcinoma cells. J Biol Chem 265: 19980–19989, 1990
Keller R, Silbert JE, Furthmayr H, Madri JA: Aortic endothelial cell proteoheparan sulfate. I. Isolation and characterization of plasma membrane-associated and extracellular species. Am J Pathol 128: 286–298, 1987
Kjellen L, Oldberg Å, Höök M: Cell-surface heparan sulfate. Mechanisms of proteoglycan-cell association. J Biol Chem 255: 10407–10413, 1980.
Jalkanen M, Rapraeger A, Bernfield M: Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins. J Cell Biol 106: 953–962, 1988
Stow JL, Farquhar MG: Distinctive populations of basement membrane and cell membrane heparan sulfate proteoglycans are produced by cultured cell lines. J Cell Biol 105: 529–539, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lowe-Krentz, L.J., Thompson, K. & Patton, W.A. Heparin releasable and nonreleasable forms of heparan sulfate proteoglycan are found on the surfaces of cultured porcine aortic endothelial cells. Mol Cell Biochem 109, 51–60 (1992). https://doi.org/10.1007/BF00230873
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00230873